Literature DB >> 18591623

Molecular characterization of acute myeloid leukemia.

Konstanze Döhner, Hartmut Döhner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18591623     DOI： 10.3324/haematol.13345

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  42 in total

Review 1.  New drugs for acute myeloid leukemia inspired by genomics and when to use them.

Authors:  Daniel A Pollyea
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the Nucleus.

Authors:  Parvathi Ranganathan; Trinayan Kashyap; Xueyan Yu; Xiaomei Meng; Tzung-Huei Lai; Betina McNeil; Bhavana Bhatnagar; Sharon Shacham; Michael Kauffman; Adrienne M Dorrance; William Blum; Deepa Sampath; Yosef Landesman; Ramiro Garzon
Journal:  Clin Cancer Res       Date:  2016-06-29       Impact factor: 12.531

3.  Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG.

Authors:  K Nowek; S M Sun; L Bullinger; E M J Bindels; C Exalto; M K Dijkstra; K van Lom; H Döhner; S J Erkeland; B Löwenberg; M Jongen-Lavrencic
Journal:  Leukemia       Date:  2015-07-15       Impact factor: 11.528

4.  MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition.

Authors:  Michael W M Kühn; Michael J Hadler; Scott R Daigle; Richard P Koche; Andrei V Krivtsov; Edward J Olhava; Michael A Caligiuri; Gang Huang; James E Bradner; Roy M Pollock; Scott A Armstrong
Journal:  Haematologica       Date:  2015-01-16       Impact factor: 9.941

Review 5.  Molecular prognostic factors in cytogenetically normal acute myeloid leukemia.

Authors:  Alison Walker; Guido Marcucci
Journal:  Expert Rev Hematol       Date:  2012-10       Impact factor: 2.929

Review 6.  Acute myeloid leukemia with normal cytogenetics.

Authors:  Raya Mawad; Elihu H Estey
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

7.  DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia.

Authors:  Sara E Meyer; Tingting Qin; David E Muench; Kohei Masuda; Meenakshi Venkatasubramanian; Emily Orr; Lauren Suarez; Steven D Gore; Ruud Delwel; Elisabeth Paietta; Martin S Tallman; Hugo Fernandez; Ari Melnick; Michelle M Le Beau; Scott Kogan; Nathan Salomonis; Maria E Figueroa; H Leighton Grimes
Journal:  Cancer Discov       Date:  2016-03-25       Impact factor: 39.397

8.  Gemtuzumab ozogamicin for treatment of newly diagnosed CD33-positive acute myeloid leukemia.

Authors:  Mohammed Gbadamosi; Soheil Meshinchi; Jatinder K Lamba
Journal:  Future Oncol       Date:  2018-07-24       Impact factor: 3.404

9.  NPM1 deletion is associated with gross chromosomal rearrangements in leukemia.

Authors:  Roberta La Starza; Caterina Matteucci; Paolo Gorello; Lucia Brandimarte; Valentina Pierini; Barbara Crescenzi; Valeria Nofrini; Roberto Rosati; Enrico Gottardi; Giuseppe Saglio; Antonella Santucci; Laura Berchicci; Francesco Arcioni; Brunangelo Falini; Massimo Fabrizio Martelli; Constantina Sambani; Anna Aventin; Cristina Mecucci
Journal:  PLoS One       Date:  2010-09-21       Impact factor: 3.240

10.  Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.

Authors:  Claudia Bănescu; Mihaela Iancu; Adrian P Trifa; Minodora Dobreanu; Valeriu G Moldovan; Carmen Duicu; Florin Tripon; Andrei Crauciuc; Cristina Skypnyk; Alina Bogliș; Erzsebeth Lazar
Journal:  Tumour Biol       Date:  2016-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.